期刊文献+

一种新型手性分子电性矩边矢量(Vmedc)的设计及其应用 被引量:5

A Vector of Molecular Electronegative Distance for Chiral Compounds(Vmedc) and Its Applications to Codification of Central Chirality
下载PDF
导出
摘要 根据分子中不同类型原子间电相互作用的不同,文中提出了一种手性分子电矩边矢量(Vmedc),进一步拓展分子电矩边性矢量(Vmed)使用范围.为检测该手性描述矢量的结构表达特性和模型预测能力,分别对32个培哚普利拉类血管紧张素转化酶(ACE)抑制剂的对映结构体和7对苯基哌啶类σ-受体抑制剂进行考察.32个ACE抑制剂多元逐步回归系数R=0.913(R2=0.834,SD=0.768,F=33.875),留一法交互检验为Rcv=0.877(Rcv2=0.769,SDcv=0.906,Fcv=22.473),具有较强预测能力;继而用BP神经网络,对60组随机样本(23:9)进行留分法分析取得较好结果,训练集平均为:RTraining=0.931(RTraining2=0.967),预测集为:Rcv=0.918(Rcv2=0.842);而对14个σ-受体抑制剂多元回归(R=0.955,Rcv2=0.849)获得与文献一致结果.再用Fisher线性判别方法和BP神经网络对ACE抑制剂进行判别分析,其活性分类88.89%正确(仅9号错误),非活性分类100.0%正确,总分类正确率为96.87%.两个数据集测试证明该方法与其它文献方法相当,这为定量构效关系(QSAR)研究提供一种新选择,扩充了Vmed描述矢量应用范围。 Based on the interaction between different atomic types, Vmedc, a novel vector of molecular electronegative distance (Vmed) has been defined and generalized in order to further codify chemical structural information for chiral drugs. Some quantitative structure-activity relationships (QSAR) have been modeled by Vmedc for both 32 stereoisomers of perindoprilate as angiotensin-converting enzyme ACE inhibitors and 7 pairs of chiral N-alkylated 3-(3-hydroxyphenyl)-piperidines that bind σ-receptors. Stepwise linear regression analysis was made forward to the 32 stereoisomers with good modeling results: R=0.913 (R^2=0.834, SD=0.768, F=33.875); Rcv=0.877 (Rcv^2=0.769, SDcv=0.906, Fcv=22.473). Furthermore, average correlation coefficients (R) for random 60 groups with 23 training compounds for all the 32 ACE stereoisomers by backpropagation neural network (BPNN) were Rtr=0.931 (R^2=0.967) and Roy=0.918 (Rcv^2=0.842), except for four groups sampled unreasonably. Compared with literatures, Vmedc has also been applied to obtain good results for 14 samples with correlation coefficient being Rcv=0.955 (Rcv^2= 0.849). Through both Fisher' linear discriminant analysis and BPNN, the 32 ACE stereoisomers were classified correctly into 88.89% active with one (#9) wrongly classified, 100.00% nonactive with no wrongly classified, and average classification of 96.87% globally. Good results obtained here were compared to those obtained with other chiral descriptors, when it was applied to the same 2 datasets, which shows that the Vmedc approach provides a powerful alternative QSAR technique for chiral compounds.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2008年第18期2052-2058,共7页 Acta Chimica Sinica
基金 国家高技术研究发展计划(863计划)专题(No.2006AA02Z312) 重庆大学研究生创新团队项目科技创新基金(No.200711C1A0010260)资助项目
关键词 ACE抑制剂 手性 Vmedc 苯基哌啶类 反传神经网络 FISHER判别分析 ACE inhibitor chiral Vmedc N-alkylated-3-(3-hydroxyphenyl)piperidine backpropagation neural network linear discriminant analysis
  • 相关文献

参考文献38

  • 1Helgakert, T.; Jorgensen, P.; Olsen, J. Molecular Electronic-Structure Theory, Wiley, Chichester, 2000.
  • 2Estrada, E.; Uriarte, E. Curr. Med. Chem. 2001, 8, 1573.
  • 3Melchert, M.; List, A. Int. J. Biochem. Cell Biol. 2007, 39, 1489.
  • 4Balaban, A. T. SAR QSAR Environ. Res. 1998, 8, 1.
  • 5Randic, M. J. Chem. Inf. Comput. Sci. 1997, 37, 672.
  • 6Zissimos, A. M.; Abraham, M. H.; Barker, M. C.; Box, K. J.; Tam, K. Y. J. Chem. Soc., Perkin Trans.II 2002, (3), 470.
  • 7Kier, L. B.; Hall, L. H. Molecular Structure Description: The Electrotopological State, Academic Press, New York, 1999.
  • 8Kubinyi, H.; Folkers, G.; Martin, Y. C. 3D QSAR in Drug Design, Recent Advances, Vol. 3, Kluwer/ESCOM, Dordrecht, 1998.
  • 9Kubinyi, H. 3D QSAR in Drug Design, Theory, Methods and Applications, ESCOM, Leiden, 1993.
  • 10Kubinyi, H.; Folkers, G.; Martin, Y. C. 3D QSAR in Drug Design, Ligand Protein Interactions and Molecular Similarity, Vol. 2, Kluwer/ESCOM, Dordrecht, 1998.

同被引文献31

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部